Claims for Patent: 8,440,721
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $100
Remove trial restrictions
Summary for Patent: 8,440,721
|Title:||Methods for concomitant administration of colchicine and a second active agent|
|Abstract:||Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided.|
|Inventor(s):||Davis; Matthew W. (Erwinna, PA)|
|Assignee:||Takeda Pharmaceuticals U.S.A., Inc. (Deerfield, IL)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 8,440,721|
1. A method of treating a patient in need of treatment for acute gout flares with colchicine, comprising orally administering an adjusted daily dosage amount of colchicine
to the patient who is receiving concomitant administration of verapamil, wherein the adjusted daily dosage amount of colchicine is 50% to 75% of an intended daily dosage amount of colchicine, wherein the intended daily dosage amount of colchicine is a
dosage amount suitable for the patient if the patient were not receiving concomitant verapamil, wherein the intended daily dosage amount of colchicine suitable for the patient if the patient were not receiving concomitant verapamil is 1.2 mg at the first
sign of flare, followed by 0.6 mg one hour later, and wherein the concomitantly administered dose of verapamil is 240 mg per day.
2. The method of claim 1, wherein the dose is not to be repeated for 3 days.
3. The method of claim 1, wherein the adjusted daily dosage amount of colchicine is 1.2 mg.
4. The method of claim 3, wherein the dose is not to be repeated for 3 days.
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.